| RS772228129 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS772228851 |
LGI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS772228887 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alagille syndrome due to a JAG1 point mutation |
| RS772228900 |
DNAH11
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS772229363 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS772229371 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, Inborn genetic diseases |
| RS772230310 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS772230378 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS772231144 |
PDHX
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3-binding protein deficiency, Pyruvate dehydrogenase E3-binding protein deficiency |
| RS772231433 |
MATR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 21, Inborn genetic diseases |
| RS772231725 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS772233041 |
ZP2
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 6, Oocyte maturation defect 6 |
| RS772233387 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS772233665 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS772234395 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS772234613 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS772235127 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS772235481 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 9, Myopathy |
| RS772235528 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS772236084 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Inborn genetic diseases |
| RS772236610 |
DNAJC19
|
Health Risk |
Likely pathogenic |
3-methylglutaconic aciduria type 5, Gastric cancer |
| RS772237527 |
HELLS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS772239348 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS772239442 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS772239586 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS772239870 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome |
| RS772240008 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Arrhythmogenic right ventricular cardiomyopathy |
| RS772240035 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS772240606 |
CPT2
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase II deficiency, myopathic form |
| RS772241382 |
PAX3
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 3, Waardenburg syndrome type 1 |
| RS772241737 |
CLDN16
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hypomagnesemia, Primary hypomagnesemia |
| RS772241929 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign recurrent intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS772242251 |
GUCY2D
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 6, Leber congenital amaurosis 1 |
| RS772243422 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Dilated cardiomyopathy 1DD |
| RS772244670 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS772245091 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS772245567 |
CKAP2L
|
Health Risk |
Conflicting classifications of pathogenicity |
Filippi syndrome, Filippi syndrome |
| RS772247940 |
CLDN19
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Renal hypomagnesemia 5 with ocular involvement |
| RS772248060 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS772248675 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS772248868 |
IFNGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 28, Inborn genetic diseases |
| RS772250170 |
PROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombophilia due to protein S deficiency, autosomal dominant |
| RS772254851 |
DNAJC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS772254904 |
DPYD
|
Health Risk |
Conflicting classifications of pathogenicity |
Dihydropyrimidine dehydrogenase deficiency, Uterine carcinosarcoma |
| RS772255929 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiovascular phenotype |
| RS772257153 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS772258197 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 3, Brugada syndrome 1 |
| RS772258959 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS772259302 |
CNGA3
|
Health Risk |
Pathogenic |
Achromatopsia 2, Achromatopsia 2 |
| RS772259344 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS772259613 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS772260091 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS772260271 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS772261260 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS772263867 |
VRK1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Pontocerebellar hypoplasia type 1A |
| RS772264078 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 4, 11 conditions |
| RS772264564 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Autosomal recessive nonsyndromic hearing loss 1A |
| RS772264918 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS772266158 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS772266373 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Cardiovascular phenotype |
| RS772266411 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS772267453 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS772267579 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, Abnormality of the nervous system |
| RS772268073 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS772268958 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS772269570 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS772269793 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS772270346 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS772273050 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS772274018 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS772274240 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS772274552 |
CLN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis |
| RS772281075 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS772282094 |
PUS7
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with abnormal behavior, microcephaly |
| RS772283403 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, See cases |
| RS772285014 |
PTS
|
Health Risk |
Likely pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS772285708 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS772286870 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Inborn genetic diseases |
| RS772287164 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS772287534 |
GNPTG
|
Health Risk |
Likely pathogenic |
GNPTG-mucolipidosis, GNPTG-mucolipidosis |
| RS772289223 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS77229108 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS772292843 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS772293748 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS772294126 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS772294235 |
ICOSLG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS772294505 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa |
| RS772294564 |
AMHR2
|
Health Risk |
Pathogenic |
Persistent Mullerian duct syndrome, Persistent Mullerian duct syndrome |
| RS772294726 |
NDUFAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS772294884 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 3 |
| RS772295351 |
ABCG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Sitosterolemia 2 |
| RS772295550 |
CFAP44
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS772295894 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS772296795 |
SERAC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylglutaconic aciduria with deafness, encephalopathy |
| RS772298089 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS772299236 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS772300180 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 13A (Zellweger), Peroxisome biogenesis disorder |
| RS772301300 |
RASA1
|
Health Risk |
Pathogenic |
Angioosteohypertrophic syndrome, Angioosteohypertrophic syndrome |
| RS772302001 |
MED27
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder with spasticity |
| RS772303730 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital glycogen storage disease of heart, Hypertrophic cardiomyopathy |